MyFinsight
Home
Blog
About
Proceeds from issuance of
debentures
$22,000,000
(388.89%↑ Y/Y)
Represents the amount of
proceeds from issuance of...
$18,307,134
Net cash provided by
financing activities
$25,529,791
(71.17%↑ Y/Y)
Effect of exchange rate
on cash, cash...
$279,566
Canceled cashflow
$14,777,343
Cash, cash
equivalent, restricted...
$18,825,916
Canceled cashflow
$6,983,441
something is missing
-$11,814,638
Repayment of debenture
$2,347,705
Cost to issue
debentures and secured...
$615,000
Increase (decrease) in
accounts payable, trade
$4,411,457
Stock-based compensation
expense
$1,405,826
(511.96%↑ Y/Y)
Represent the amount of
issuance of common shares...
$378,070
Paid-in-kind interest
$101,340
Represents the amount of
operating lease...
$27,147
(-42.93%↓ Y/Y)
Increase (decrease) in
accounts payable,...
$14,623
(169.02%↑ Y/Y)
Net cash used in
operating activities
-$6,983,441
(25.79%↑ Y/Y)
Canceled cashflow
$6,338,463
Net loss for the
period
-$11,684,427
Prepaid expenses
$876,667
(674.43%↑ Y/Y)
Increase (decrease) in
accounts payable and...
-$724,721
(-168.02%↓ Y/Y)
Increase (decrease) in
operating lease liability
-$36,091
(35.68%↑ Y/Y)
Back
Back
Cash Flow
Medicus Pharma Ltd. (MDCX)
Medicus Pharma Ltd. (MDCX)
source: myfinsight.com